Search results
Results from the WOW.Com Content Network
The major shortcoming of most patient portals is their linkage to a single health organization. If a patient uses more than one organization for healthcare, the patient typically needs to log on to each organization's portal to access information. This results in a fragmented view of individual patient data. [3]
Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts.Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
Ciox Health was created by the merger of HealthPort, IOD Inc., Care Communications Inc. and ECS. It serves more than 18,000 provider sites, 140 health plans and 1 million unique requesters of patient information. [2] In June 2021, Ciox Health was acquired by San Francisco-based Datavant in a $7B deal.l [3]
Wellstar Health System (formerly WellStar) is a non-profit system founded in 1993 providing comprehensive care in Metro Atlanta, Georgia, United States. It includes: Augusta University Medical Center [1] Center for Health Transformation; Spalding Regional Hospital [2] Sylvan Grove Hospital [2] Wellstar Cobb Hospital, Austell, Georgia
Emory Crawford Long Hospital was renamed "Emory University Hospital Midtown", effective February 13, 2009, in order to more clearly identify it as part of the university. [5] However, as part of Emory's commitment to honor a more than 100-year history of the original name, 'Crawford W. Long Memorial Hospital' is retained on exterior monuments.
In 2014, Freeman received the William B. Coley Award along with Tasuku Honjo, Lieping Chen and Arlene Sharpe. [3]In 2017, Freeman was one of the winners of the Warren Alpert Foundation Prize, and in 2022 he was elected to the American Academy of Arts and Sciences and the National Academy of Sciences.
Edward J. Benz Jr. is the former president of Dana–Farber Cancer Institute in Boston, Massachusetts., [1] and the Richard and Susan Smith Professor of Medicine [2] as well as a professor of genetics at Harvard Medical School. [3] He was named to the presidency of Dana-Farber in 2000, succeeding David G. Nathan. [4]
He is currently Professor of Medicine at Harvard Medical School, Chair of Medical Oncology at Dana–Farber Cancer Institute, and Director of Medical Oncology at Brigham and Women's Hospital. [1] [2] He is considered an expert in medical oncology and is widely recognized for his research in the clinical and biologic aspects of hemotologic ...